A new drug called OXO-001 has shown promising results in improving IVF success rates, leading to a 7% increase in live births.
The drug targets the lining of the womb, making it more receptive to the implanted embryo.
In a trial, women who took OXO-001 had higher rates of pregnancy and were more likely to have a baby at 10 weeks.
This drug could be a game-changer for people struggling with infertility, as it offers a non-hormonal approach to boosting IVF success.
